---
title: "Freda: Net profit of 108 million yuan in the first half of 2025, a year-on-year decrease of 15.16%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253994578.md"
description: "Freda announced that its operating revenue in the first half of 2025 was 1.79 billion yuan, a year-on-year decrease of 7.05%. Net profit was 108 million yuan, a year-on-year decrease of 15.16%"
datetime: "2025-08-21T12:22:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253994578.md)
  - [en](https://longbridge.com/en/news/253994578.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253994578.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/253994578.md) | [繁體中文](https://longbridge.com/zh-HK/news/253994578.md)


# Freda: Net profit of 108 million yuan in the first half of 2025, a year-on-year decrease of 15.16%

Freda announced that its operating revenue in the first half of 2025 was 1.79 billion yuan, a year-on-year decrease of 7.05%. The net profit was 108 million yuan, a year-on-year decrease of 15.16%

### Related Stocks

- [Freda (600223.CN)](https://longbridge.com/en/quote/600223.CN.md)

## Related News & Research

- [Hengrui Pharmaceuticals Obtains Nod for Lung Cancer Combo Drug Trials](https://longbridge.com/en/news/277871128.md)
- [Trelleborg Tightens Climate Goals With SBTi-Validated Net-Zero Path](https://longbridge.com/en/news/278068478.md)
- [U.S. Interior Secretary arrives in Venezuela to discuss energy, minerals](https://longbridge.com/en/news/277804766.md)
- [Hengrui Pharmaceuticals Gets Clinical Trial Nod for Hypertension Drug](https://longbridge.com/en/news/277870666.md)
- [10:51 ETCFX PROJECTS RECEIVE PRESTIGIOUS ACEC 2026 ENGINEERING EXCELLENCE AWARDS](https://longbridge.com/en/news/277806284.md)